Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5630880

O=C(O)C(F)(F)F.OCCNCc1nonc1/C(=N\O)Nc1ccc(F)c(Cl)c1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
SLC2A1 P11166 1/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 3/20 0.39
MAPT P10636 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPC1 O15118 3/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5630919 1.00 MEN1 (0.40) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
SCHEMBL5631734 0.93 MEN1 (0.40) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
SCHEMBL5631754 0.93 MEN1 (0.40) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
Trifluoroacetic Acid SCHEMBL5632007 0.89 SMN1; SMN2 (0.45) MEN1KMT2AL3MBTL1SMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL5631999 0.89 SMN1; SMN2 (0.45) MEN1KMT2AL3MBTL1SMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL5633201 0.88 SMN1; SMN2 (0.41) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
Trifluoroacetic Acid SCHEMBL5633194 0.88 SMN1; SMN2 (0.41) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
Trifluoroacetic Acid SCHEMBL5630463 0.88 CYP1A2 (0.41) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
Trifluoroacetic Acid SCHEMBL5630479 0.88 CYP1A2 (0.41) MEN1KMT2AL3MBTL1SMN1; SMN2SLC2A1
Trifluoroacetic Acid SCHEMBL15093525 0.88 SMN1; SMN2 (0.44) MEN1KMT2AL3MBTL1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450351-B2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2013-05-28 US disclosed
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase IDO1, IDO2, HNMT MEN1 1163/4885KMT2A 545/4885L3MBTL1 4311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.